Suchergebnisse - "Imai, Yukinori"

PubPharm (6)

1

Superiority of tenofovir alafenamide fumarate over entecavir for serum HBsAg level reduction in patients with chronic HBV infection : A 144-week outcome study after switching of the nucleos(t)ide analog

enthalten in: PloS one | 2022

von Uchida, Y. | Nakao, M. | Yamada, S. | +9

2

Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate

enthalten in: Journal of medical virology | 2020

von Uchida, Y. | Nakao, M. | Tsuji, S. | +9

ErratumIn: J Med Virol. 2020 Aug;92(8):1370. - PMID 32677098

3

NS5A-P32 deletion as a factor involved in virologic failure in patients receiving glecaprevir and pibrentasvir

enthalten in: Journal of gastroenterology | 2019

von Uemura, H. | Uchida, Y. | Kouyama, J. | +9

4

Significance of NS5B Substitutions in Genotype 1b Hepatitis C Virus Evaluated by Bioinformatics Analysis

enthalten in: Scientific reports | 2018

von Uchida, Y. | Nakamura, S. | Kouyama, J. | +11

5

Serum asunaprevir concentrations showing correlation with the extent of liver fibrosis as a factor inducing liver injuries in patients with genotype-1b hepatitis C virus receiving daclatasvir plus asunaprevir therapy

enthalten in: PloS one | 2018

von Uchida, Y. | Naiki, K. | Kouyama, J. | +8

6

Significance of variants associated with resistance to NS5A inhibitors in Japanese patients with genotype 1b hepatitis C virus infection as evaluated using cycling-probe real-time PCR combined with direct sequencing

enthalten in: Journal of gastroenterology | 2016

von Uchida, Y. | Kouyama, J. | Naiki, K. | +8

1
[1]